A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
Clinical trial NCT07585266 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07585266
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-10
- Primary completion
- 2032-09-06
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.